BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12717415)

  • 1. v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
    Maclaren A; Clark W; Black EJ; Gregory D; Fujii H; Gillespie DA
    Oncogene; 2003 Apr; 22(16):2383-95. PubMed ID: 12717415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest.
    Burdon D; Patel R; Challiss RA; Blank JL
    Biochem J; 2002 Oct; 367(Pt 2):549-59. PubMed ID: 12126481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
    Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
    Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors.
    Clark W; Gillespie DA
    Cell Growth Differ; 1997 Apr; 8(4):371-80. PubMed ID: 9101083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1).
    Op De Beeck A; Sobczak-Thepot J; Sirma H; Bourgain F; Brechot C; Caillet-Fauquet P
    J Virol; 2001 Nov; 75(22):11071-8. PubMed ID: 11602746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
    Miyazaki M; Ohashi R; Tsuji T; Mihara K; Gohda E; Namba M
    Biochem Biophys Res Commun; 1998 May; 246(3):873-80. PubMed ID: 9618305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
    Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
    Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA stimulates IEC-6 cell proliferation by increasing polyamine-dependent Cdk2 activity.
    Guo H; Ray RM; Johnson LR
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G704-13. PubMed ID: 12816757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1.
    Meng LH; Zhang H; Hayward L; Takemura H; Shao RG; Pommier Y
    Cancer Res; 2004 Dec; 64(24):9086-92. PubMed ID: 15604277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
    Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
    Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation.
    Asada M; Yamada T; Ichijo H; Delia D; Miyazono K; Fukumuro K; Mizutani S
    EMBO J; 1999 Mar; 18(5):1223-34. PubMed ID: 10064589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells.
    Chen J; Willingham T; Shuford M; Bruce D; Rushing E; Smith Y; Nisen PD
    Oncogene; 1996 Oct; 13(7):1395-403. PubMed ID: 8875977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein induces p21(Cip1/WAF1) expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells.
    Kuzumaki T; Kobayashi T; Ishikawa K
    Biochem Biophys Res Commun; 1998 Oct; 251(1):291-5. PubMed ID: 9790949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.